Clinical Trials Directory

Trials / Completed

CompletedNCT02213055

Pediatric Head Lice Study Product Comparison

Safety and Efficacy of a 100% Dimethicone Pediculocide in School-Age Children

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
97 (actual)
Sponsor
Hackensack Meridian Health · Academic / Other
Sex
All
Age
3 Years – 12 Years
Healthy volunteers
Not accepted

Summary

* To evaluate the efficacy of LiceMD for the treatment of head lice in a pediatric population. * To evaluate the safety of LiceMD in a pediatric population.

Detailed description

Head lice, or Pediculus humanus capitis, cause an estimated 6 to 12 million infestations per year in the U.S., most commonly affecting children 3 to 11 years of age. Despite common perceptions, head lice crawl, and cannot hop or fly. For this reason, transmission occurs most often by human head-to-head contact, and much less commonly by the sharing of personal items such as hats, coats, combs, or towels. Because head lice feed on human blood, they cannot live on pets and are only viable 1-2 days on surfaces other than the human head.

Conditions

Interventions

TypeNameDescription
DRUGLICEMDParents/guardians of infested children will provide consent for their child's participation. Infested children whose parents agree to use the investigational product will be enrolled on the experimental arm of the study using the LiceMD product as treatment. Participants will be examined for lice count and scalp irritation the day after the first application, and one and two weeks after the first application.
DRUGStandard Head lice productThe most common treatments are pesticide-based, over-the-counter remedies of permethrin (1%), or pyrethrin-based products.After baseline scalp exam for lice count and preexisting signs of irritation, parents who agree to the comparison arm may purchase any other head lice treatment of their choice. All treatments are to be done at home by a parent or guardian. All participants will be examined for lice count and scalp irritation the day after the first application, and one and two weeks after the first application. Participants may also be examined by parents or the school nurse at any time if signs of irritation or re-infestation occur. If the child is still found to be infested during any examination, the school nurse will instruct the parent/guardian to retreat.

Timeline

Start date
2009-05-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2014-08-11
Last updated
2016-07-29
Results posted
2016-07-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02213055. Inclusion in this directory is not an endorsement.